Medscape |
REMOVAL: Mixed Data on CV Benefits of Metformin in Type 1 Diabetes
Medscape The multicenter trial randomized a total of 428 adults aged 40 and older with type 1 diabetes and at increased cardiovascular risk to daily metformin 1000 mg twice daily or placebo as adjuncts to insulin. The primary end point — significant reduction ... Cheap drug could cut risk of heart disease among diabetes sufferers, scientists discover Drug found to improve heart health of type 1 diabetes |
Social Plugin